tiprankstipranks
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market

Symbio Pharmaceuticals Limited (4582) Income Statement

Compare
1 Followers

Symbio Pharmaceuticals Limited Income Statement

Last quarter (Q2 2024), Symbio Pharmaceuticals Limited's total revenue was ¥686.56M, a decrease of -57.98% from the same quarter last year. In Q2, Symbio Pharmaceuticals Limited's net income was ¥-763.94M. See Symbio Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 5.59B¥ 10.01B¥ 8.25B¥ 2.99B¥ 2.84B
Gross Profit
¥ 4.41B¥ 7.60B¥ 5.80B¥ 866.85M¥ 864.75M
Operating Expenses
¥ 5.22B¥ 5.64B¥ 4.78B¥ 5.37B¥ 5.17B
Depreciation and Amortization
¥ 96.00M¥ 98.09M¥ 93.96M¥ 63.84M¥ 38.09M
EBITDA
¥ -714.00M¥ 2.20B¥ 1.11B¥ -4.44B¥ -4.26B
Operating Income
¥ -811.67M¥ 1.96B¥ 1.02B¥ -4.51B¥ -4.30B
Other Income/Expenses
¥ -383.72M¥ 142.65M¥ -14.67M¥ 419.80M¥ -70.84M
Pretax Income
¥ -1.20B¥ 2.11B¥ 1.00B¥ -4.09B¥ -4.37B
Net Income
¥ -1.96B¥ 1.18B¥ 2.03B¥ -4.09B¥ -4.38B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -49.19¥ 30.20¥ 53.04¥ -124.13¥ -189.03
Diluted EPS
¥ -49.19¥ 29.77¥ 52.32¥ -124.13¥ -189.03
Weighted Average Shares Outstanding
39.90M 39.05M 38.31M 32.95M 23.15M
Weighted Average Shares Outstanding (Diluted)
39.90M 39.61M 38.84M 32.95M 23.15M
Currency in JPY

Symbio Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis